# Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/health-related-quality-of-life-with-trastuzumab-monotherapy-versus-trastuzumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Naruto Taira,Masataka Sawaki,Yukari Uemura,Tsuyoshi Saito,Shinichi Baba,Kokoro Kobayashi,Hiroaki Kawashima,Michiko Tsuneizumi,Noriko Sagawa,Hiroko Bando,Masato Takahashi,Miki Yamaguchi,Tsutomu Takashima,Takahiro Nakayama,Masahiro Kashiwaba,Toshiro Mizuno,Yutaka Yamamoto,Hiroji Iwata,Yasuo Ohashi,Hirofumi Mukai,Takuya Kawahara,for the RESPECT Study Group |
| Citations | 38 |
| DOI | 10.1200/jco.20.02751 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3148459923 |
| PMID | 33835842 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Takuya Kawahara](https://scholariq.org/researchers/takuya-kawahara/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.